The Effects of Intelligent Intervention Programs on Hospitalized Elderly People With Frailty.

NCT ID: NCT06875024

Last Updated: 2025-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

156 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-15

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: As the aging population grows, hospitalized elderly individuals with frailty have become a major concern. Frailty is a complex syndrome linked to aging, marked by dependency and vulnerability. Elderly patients often face chronic diseases, making them more susceptible to frailty. Studies show frailty prevalence in hospitalized elderly patients is 88.7%, and 75.3% among kidney disease patients. Frailty is associated with advanced age, female gender, low body mass index, comorbidities, and poor nutrition, increasing the risks of falls, hospitalization, and mortality. Frail kidney disease patients face worse outcomes. However, frailty is reversible with early intervention. Current treatments, based on comprehensive geriatric assessment (CGA), require significant resources. This study aims to explore frailty prevention and care through research and intervention development.

Purpose: To explore the effectiveness of an intelligent intervention program in improving frailty among hospitalized elderly individuals.

Methods: An experimental research design was adopted. A total of 156 hospitalized elderly patients with kidney disease who met the inclusion criteria were recruited through convenience sampling. Participants were randomly assigned to either the experimental group (n = 78) or the control group (n = 78). The experimental group received a 12-week intelligent intervention program, while the control group received routine care.Subsequently, data on frailty level, daily living function 30 days after discharge, and unexpected readmission rate 30 days after discharge will be collected by researchers and analyzed using SPSS 22.0, including chi-square tests, repeated measures ANOVA, and Generalized Estimating Equations (GEE) for intra-group and inter-group comparisons of each outcome variable.

Expected research results: This study aims to understand the current status and influencing factors of frailty among hospitalized elderly patients with kidney disease and to develop an intelligent intervention program. The goal is to provide clinical nursing staff with a frailty care strategy for hospitalized patients, effectively reducing frailty among elderly inpatients, improving their daily functional ability after discharge, and decreasing hospital readmission rates.

Condition or disease: frailty Intervention/treatment: intelligent intervention program

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

Frailty is an aging-related syndrome with a prevalence that increases with age. However, frailty should not be considered a natural part of aging; rather, it involves multiple factors such as dependency, dynamic processes, and vulnerability . Hospitalized elderly individuals often suffer from chronic diseases and are in a stage of aging with declining physical function. During acute illness, they experience physical weakness and disease burden, which, combined with the stress and physical strain of hospitalization, prolonged bed rest, and reduced activity levels, makes them more susceptible to frailty. According to domestic research, the prevalence of frailty among hospitalized elderly patients in Taiwan is as high as 88.7% .

Frailty is significantly associated with advanced age, female gender, body mass index, comorbidities, activities of daily living (ADL), and poor nutritional status. Among patients with kidney disease, frailty-related risk factors such as fatigue, reduced activity, and decreased albumin levels are more common. Studies indicate that the prevalence of frailty among patients with kidney disease reaches 75.3%. Additionally, compared to non-frail patients with kidney disease, frail patients with kidney disease have a 2.75-fold increased risk of mortality, a 3.79-fold higher risk of discharge to long-term care facilities, an extended hospitalization duration of 4.87 days, and an increased hospital cost of $41,025.03. These findings suggest that frailty significantly increases the risk of adverse health outcomes in patients with kidney disease .

Current research indicates that frailty is reversible. A large-scale study in Europe found that early intervention during the pre-frailty or mild frailty stage is far more effective than intervention at later stages. In recent years, studies have explored multimodal interventions to mitigate frailty in hospitalized elderly patients. However, the number of randomized controlled trials remains limited, and existing studies are of low quality, with inconsistent intervention strategies and outcomes.

Furthermore, most interventional studies have been based on comprehensive geriatric assessment (CGA) and employed the Acute Care for Elderly (ACE) model, requiring interdisciplinary coordination and integration across multiple specialties . However, the organizational requirements for CGA and ACE models are substantial, making it difficult for clinical settings lacking the necessary infrastructure to implement these interventions effectively.

Therefore, this study aims to conduct a prospective investigation and develop interventional strategies to prevent and manage frailty among hospitalized elderly patients with kidney disease.

Purpose:

1. Develop an intelligent intervention program for frailty.
2. Evaluate the effectiveness of the intelligent frailty intervention program in reducing frailty levels among hospitalized elderly patients with kidney disease before discharge.
3. Assess the impact of the intelligent frailty intervention program on the daily functional abilities of hospitalized elderly patients with kidney disease.
4. Examine the effect of the intelligent frailty intervention program on the 30-day unplanned readmission rate of hospitalized elderly patients with kidney disease.

Subjects:

1. Inclusion criteria: (1) Hospitalized patients aged 65 years and older.(2) Admitted to the nephrology department or undergoing dialysis.(3) Conscious, able to express themselves independently, follow instructions, and communicate in Mandarin or Taiwanese.(4) Expected hospital stay of at least six days.(5) Assessed using the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and deemed to have no immediate risk for exercise participation, with normal capability for physical activity.
2. Exclusion criteria: (1) Severe visual or hearing impairments that hinder communication or assessments.(2) Significant cognitive impairment, defined as a Montreal Cognitive Assessment (MoCA) score \< 24.(3) Patients who do not consent to participate in the study.(4) Individuals unable to personally complete the consent form.(5) Patients receiving palliative care.(6) Regular participants in rehabilitation therapy.(7) Charlson Comorbidity Index (CCI) score ≥ 5.
3. Number of subjects: 78 in the experimental group and 78 in the control group
4. Recruitment method: (1) Recruitment location: A medical ward in a regional teaching hospital in northern Taiwan. (2) Recruitment through: Participants will be referred by physicians.

Research design:

1. Study design or implementation This study is a randomized clinical trial (RCT) investigating the effectiveness of an intelligent intervention program on frailty levels, daily living functions, and unexpected readmission rates among hospitalized elderly patients with kidney disease. The study adopts a double-blind, parallel-group randomized design. Eligible participants will be recruited through convenience sampling and subsequently assigned to two groups using block randomization. The experimental group will receive the intelligent intervention program, while the control group will receive standard care. The intervention involves a structured exercise program, with participants in the experimental group engaging in cycling exercises three times per week, each session lasting 30 minutes during hospitalization. After discharge, they will follow a walking program, increasing their daily step count by 1,000 steps above the average recorded during hospitalization, for a total of 12 weeks. Participant in the control group will wear a smart wristband but will only receive standard care. Structured questionnaires and medical records will be used for data collection at four time points: the first week of enrollment (T0), hospital discharge (T1), the eighth week post-enrollment (T2), and the twelfth week post-enrollment (T3). Additionally, a tri-axial accelerometer-equipped smart wristband will be used to monitor and record participants' heart rate, respiration, blood pressure, daily step count, and sleep quality.
2. Project duration and expected progress

(1) This study was conducted after IRB and RCT were approved until 12/31/2025 (2) The case will be accepted after approval by both IRB and RCT. (3) Conduct data analysis and statistics after receiving the case 3. Statistical methods and results evaluation

1. Descriptive data analysis

①. Frequency distribution and percentages will be used to describe demographic variables, disease characteristics, and frailty, including age, gender, education level, marital status, economic status, body mass index (BMI), medication history, fall history, reason for hospitalization, types of chronic diseases, dialysis status, comorbidities, and frailty status.

②. Continuous variables, including physical function, nutritional status, cognitive function, depression index, frailty level, daily step count, and daily activity level, will be described using mean, standard deviation, minimum, maximum, and range.
2. Inferential Data Analysis To examine factors associated with the study participants, independent sample t-tests and one-way analysis of variance (ANOVA) will be used to analyze the relationships between basic characteristics, disease attributes, and frailty levels. Pearson's correlation will be used to explore the relationships between physical function, nutritional status, cognitive function, depression index, and frailty level. Logistic regression analysis will be conducted to identify predictors of frailty among hospitalized elderly patients. For evaluating the effectiveness of the intervention, independent sample t-tests and chi-square tests will be used to assess the homogeneity of demographic variables, disease characteristics, frailty, physical function, nutritional status, cognitive function, depression index, frailty level, daily step count, and daily activity level between the two groups. Repeated measures ANOVA and binary logistic regression analysis will be applied to assess between-group differences in the intervention group. Generalized estimating equations (GEE) will be used to analyze the differences in intervention effectiveness between the two groups, as well as the interaction effects between group and time.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frailty in Older Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

The control group received usual care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Experimental group

The experimental group will receive an intelligent intervention program, which includes cycling training during hospitalization and daily walking training after discharge, supplemented by monitoring and tracking using a smart wristband.

Group Type EXPERIMENTAL

Intelligent intervention programs

Intervention Type BEHAVIORAL

The intervention involves a structured exercise program, with participants in the experimental group engaging in cycling exercises three times per week, each session lasting 30 minutes during hospitalization. After discharge, they will follow a walking program, increasing their daily step count by 1,000 steps above the average recorded during hospitalization, for a total of 12 weeks. Structured questionnaires and medical records will be used for data collection at four time points: the first week of enrollment (T0), hospital discharge (T1), the eighth week post-enrollment (T2), and the twelfth week post-enrollment (T3). Additionally, a tri-axial accelerometer-equipped smart wristband will be used to monitor and record participants' heart rate, respiration, blood pressure, daily step count, and sleep quality.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intelligent intervention programs

The intervention involves a structured exercise program, with participants in the experimental group engaging in cycling exercises three times per week, each session lasting 30 minutes during hospitalization. After discharge, they will follow a walking program, increasing their daily step count by 1,000 steps above the average recorded during hospitalization, for a total of 12 weeks. Structured questionnaires and medical records will be used for data collection at four time points: the first week of enrollment (T0), hospital discharge (T1), the eighth week post-enrollment (T2), and the twelfth week post-enrollment (T3). Additionally, a tri-axial accelerometer-equipped smart wristband will be used to monitor and record participants' heart rate, respiration, blood pressure, daily step count, and sleep quality.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospitalized patients aged 65 years and older. (、
* Admitted to the nephrology department or undergoing dialysis.
* Conscious, able to express themselves independently, follow instructions, and communicate in Mandarin or Taiwanese.
* Expected hospital stay of at least six days.
* Assessed using the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and deemed to have no immediate risk for exercise participation, with normal capability for physical activity.

Exclusion Criteria

* Severe visual or hearing impairments that hinder communication or assessments.
* Significant cognitive impairment, defined as a Montreal Cognitive Assessment (MoCA) score \< 24.
* Patients who do not consent to participate in the study.
* Individuals unable to personally complete the consent form.
* Patients receiving palliative care.
* Regular participants in rehabilitation therapy.
* Charlson Comorbidity Index (CCI) score ≥ 5.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taipei University of Nursing and Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chia Jung Hsieh

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taipei University of Nursing and Health Sciences, Taipei,

Taipei, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chia Jung Hsieh

Role: CONTACT

886 2 28227101 ex 3109

Hsuan Ju Peng

Role: CONTACT

886 953625708

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hsuan Ju Peng

Role: primary

8869536257078

References

Explore related publications, articles, or registry entries linked to this study.

Zotcheva E, Haberg AK, Wisloff U, Salvesen O, Selbaek G, Stensvold D, Ernstsen L. Effects of 5 Years Aerobic Exercise on Cognition in Older Adults: The Generation 100 Study: A Randomized Controlled Trial. Sports Med. 2022 Jul;52(7):1689-1699. doi: 10.1007/s40279-021-01608-5. Epub 2021 Dec 8.

Reference Type BACKGROUND
PMID: 34878637 (View on PubMed)

Yeh AY, Pressler SJ, Algase D, Struble LM, Pozehl BJ, Berger AM, Giordani BJ. Sleep-Wake Disturbances and Episodic Memory in Older Adults. Biol Res Nurs. 2021 Apr;23(2):141-150. doi: 10.1177/1099800420941601. Epub 2020 Jul 10.

Reference Type BACKGROUND
PMID: 32648471 (View on PubMed)

Wilkinson TJ, Miksza J, Zaccardi F, Lawson C, Nixon AC, Young HML, Khunti K, Smith AC. Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2426-2435. doi: 10.1002/jcsm.13047. Epub 2022 Jul 19.

Reference Type BACKGROUND
PMID: 35851589 (View on PubMed)

Wei YC, Chen CK, Lin C, Chen PY, Hsu PC, Lin CP, Shyu YC, Huang WY. Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment, and Alzheimer's Disease Assessment Scale-Cognitive Subscale of Community-Dwelling Older Adults in Taiwan. Dement Geriatr Cogn Disord. 2022;51(4):365-376. doi: 10.1159/000525615. Epub 2022 Jul 12.

Reference Type BACKGROUND
PMID: 35820405 (View on PubMed)

Pan, A. N., Lin, V. L., Hsu, P. C. & Chen, H. C.(2022) The Associations of Subjective and Objective Sleep Quality and Mood Symptoms among Patients with Bipolar Disorder: A Longitudinal Study. The Journal of Psychiatric Mental Health Nursing, 17(3), 26-36. https://doi-org.mhdla.flysheet.com.tw:8443/10.6847/TJPMHN.202212_17(3).04

Reference Type BACKGROUND

Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. doi: 10.1111/j.1532-5415.2005.53221.x.

Reference Type BACKGROUND
PMID: 15817019 (View on PubMed)

Gregg LP, Bossola M, Ostrosky-Frid M, Hedayati SS. Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment. Clin J Am Soc Nephrol. 2021 Sep;16(9):1445-1455. doi: 10.2215/CJN.19891220. Epub 2021 Apr 15.

Reference Type BACKGROUND
PMID: 33858827 (View on PubMed)

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56. doi: 10.1093/gerona/56.3.m146.

Reference Type BACKGROUND
PMID: 11253156 (View on PubMed)

Ekerstad N, Dahlin Ivanoff S, Landahl S, Ostberg G, Johansson M, Andersson D, Husberg M, Alwin J, Karlson BW. Acute care of severely frail elderly patients in a CGA-unit is associated with less functional decline than conventional acute care. Clin Interv Aging. 2017 Aug 8;12:1239-1249. doi: 10.2147/CIA.S139230. eCollection 2017.

Reference Type BACKGROUND
PMID: 28848332 (View on PubMed)

Chou, M.-H., Chen, F.-J., Chiu, C.-F., & Lin, Y.-D. (2019). Frailty status and its influencing factors among elderly hospitalized patients. The VGH Nursing, 36(1), 27-38. https://doi.org/10.6142/vghn.201903_36(1).0003

Reference Type BACKGROUND

Chin, W. C., Liu, C. Y., Lee, C. P., & Chu, C. L. (2014). Validation of Five Short Versions of the Geriatric Depression Scale in the Elder Population in Taiwan. Taiwanese Journal of Psychiatry, 28 (3), 156-163+ii. https://www-airitilibrary-com.mhdla.flysheet.com.tw:8443/Article/Detail?DocID=10283684-201409-201410200065-201410200065-156-163+ii

Reference Type BACKGROUND

Checa-Lopez M, Costa-Grille A, Alvarez-Bustos A, Carnicero-Carreno JA, Sinclair A, Scuteri A, Landi F, Solano-Jaurrieta JJ, Bellary S, Rodriguez-Manas L. Effectiveness of a randomized intervention by a geriatric team in frail hospital inpatients in non-geriatric settings: FRAILCLINIC project. J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):361-369. doi: 10.1002/jcsm.13374. Epub 2023 Nov 28.

Reference Type BACKGROUND
PMID: 38014479 (View on PubMed)

Chang, H. Y., Hsieh, Y. W., Hsueh, I. P. & Hsieh, C. L. (2006). A Forty-year Retrospective of Assessment of Activities of Daily Living. Taiwan Journal of Physical Medicine and Rehabilitation,34(2), 63-71. https://doi-org.mhdla.flysheet.com.tw:8443/10.6315/2006.34(2)01

Reference Type BACKGROUND

Tsai PS, Wang SY, Wang MY, Su CT, Yang TT, Huang CJ, Fang SC. Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res. 2005 Oct;14(8):1943-52. doi: 10.1007/s11136-005-4346-x.

Reference Type BACKGROUND
PMID: 16155782 (View on PubMed)

Neborak JM, Press VG, Parker WF, Rojas JC, Byron M, Goyal S, Meltzer DO, Mokhlesi B, Arora VM. Association of preadmission insomnia symptoms with objective in-hospital sleep and clinical outcomes among hospitalized patients. J Clin Sleep Med. 2024 May 1;20(5):681-687. doi: 10.5664/jcsm.10964.

Reference Type BACKGROUND
PMID: 38156422 (View on PubMed)

Jiang X, Li D, Shen W, Shen X, Liu Y. In-Hospital Outcomes of Patients on Maintenance Dialysis With Frailty: 10-year Results From the US National Inpatient Sample Database. J Ren Nutr. 2020 Nov;30(6):526-534. doi: 10.1053/j.jrn.2019.12.007. Epub 2020 Feb 13.

Reference Type BACKGROUND
PMID: 32063457 (View on PubMed)

Jarach CM, Tettamanti M, Nobili A, D'avanzo B. Social isolation and loneliness as related to progression and reversion of frailty in the Survey of Health Aging Retirement in Europe (SHARE). Age Ageing. 2021 Jan 8;50(1):258-262. doi: 10.1093/ageing/afaa168.

Reference Type BACKGROUND
PMID: 32915990 (View on PubMed)

Jaiswal SJ, Kang DY, Wineinger NE, Owens RL. Objectively measured sleep fragmentation is associated with incident delirium in older hospitalized patients: Analysis of data collected from an randomized controlled trial. J Sleep Res. 2021 Jun;30(3):e13205. doi: 10.1111/jsr.13205. Epub 2020 Oct 13.

Reference Type BACKGROUND
PMID: 33051948 (View on PubMed)

Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

Reference Type BACKGROUND
PMID: 2748771 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CJHsieh

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Successful Aging and Frailty
NCT03963050 UNKNOWN NA